These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19893556)

  • 21. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
    Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
    Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children].
    Desheva IuA; Danini GV; Grigor'eva EP; Donina SA; Kiseleva IV; Rekstin AR; Ermakova LA; Natsina VK; Nikolaeva VM; Lonskaia NI; El'shina GA; Zhavoronkov VG; Drinevskiĭ VP; Erofeeva MK; Naĭkhin AN; Rudenko LG
    Vopr Virusol; 2002; 47(4):21-4. PubMed ID: 12271720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances in research and development of universal influenza vaccines].
    Zhang LX; Zhou JF; Shu YL; Yang BS; He ZQ
    Bing Du Xue Bao; 2014 Jan; 30(1):73-8. PubMed ID: 24772902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine.
    Coughlan L; Palese P
    Cell Host Microbe; 2018 Jul; 24(1):18-24. PubMed ID: 30001520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years].
    Grigor'eva EP; Desheva IuA; Donina SA; Naĭkhin AN; Rekstin AR; Barantseva IB; Zavitkova EA; Moskvicheva TM; Zhavoronkov VG; Rudenko LG
    Vopr Virusol; 2002; 47(4):24-7. PubMed ID: 12271721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress on adenovirus-vectored universal influenza vaccines.
    Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S
    Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery.
    Martinez O; Tsibane T; Basler CF
    Int Rev Immunol; 2009; 28(1):69-92. PubMed ID: 19241254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slowing Influenza Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities in Vaccination Strategies.
    Lafont BAP; Bennink JR
    Viral Immunol; 2020 Apr; 33(3):197-200. PubMed ID: 32286176
    [No Abstract]   [Full Text] [Related]  

  • 30. Influenza: girding for disaster. Searching for all-powerful flu weapons.
    Kaiser J
    Science; 2004 Oct; 306(5695):395. PubMed ID: 15486268
    [No Abstract]   [Full Text] [Related]  

  • 31. T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine.
    Schmidt A; Lapuente D
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33525620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Broadly neutralizing antibodies and the promise of universal vaccines: where are we now?
    Hefferon KL
    Immunotherapy; 2014; 6(1):51-7. PubMed ID: 24341884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Perspective on Nanoparticle Universal Influenza Vaccines.
    Deng L; Wang BZ
    ACS Infect Dis; 2018 Dec; 4(12):1656-1665. PubMed ID: 30394725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccine in the red zone defense: a game-day player.
    Peters TR; Poehling KA
    J Infect Dis; 2014 Sep; 210(5):671-3. PubMed ID: 24676206
    [No Abstract]   [Full Text] [Related]  

  • 35. Influenza vaccines: a moving interdisciplinary field.
    Schotsaert M; García-Sastre A
    Viruses; 2014 Oct; 6(10):3809-26. PubMed ID: 25302957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influenza vaccination? An extra vaccine for seniors?].
    MMW Fortschr Med; 2003 Sep; 145(37):61. PubMed ID: 14584449
    [No Abstract]   [Full Text] [Related]  

  • 37. Antigenic response to influenza virus in man. II. Neutralizing antibody response to inactivated monovalent B vaccine, with observations on vaccine efficacy during a subsequent type B epidemic.
    Brown P; Gajdusek DC; Chen KM; Morris JA
    Am J Epidemiol; 1969 Oct; 90(4):336-43. PubMed ID: 5823444
    [No Abstract]   [Full Text] [Related]  

  • 38. Flu Universal Vaccines: New Tricks on an Old Virus.
    Du R; Cui Q; Rong L
    Virol Sin; 2021 Feb; 36(1):13-24. PubMed ID: 32870450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flu in 15: a novel 15-minute education program to promote acceptance of the influenza vaccine among health care workers.
    Butteri MJ; Radu C; Huq F; Wiglesworth A; Durso SC; Bellantoni M
    J Am Med Dir Assoc; 2010 Sep; 11(7):523-7. PubMed ID: 20816342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diversification of influenza viruses].
    Marian CV; Mihăescu G
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(2):117-23. PubMed ID: 20422926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.